DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jkgp75/global_intranasal) has announced the addition of the "Global Intranasal Drug Delivery Market 2014-2018" report to their offering.
The Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018.
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.
One of the emerging trends that the market is likely to experience is an increasing adoption of non-invasive administration products. As non-invasive nasal drug delivery increases the compliance of the patient through their convenient application, they find more preference among end-users.
According to the report, one of the major drivers in the market is the increasing aging population. With growing age, people are more susceptible to developing respiratory diseases. Hence, that is an important factor in increasing the demand for intranasal drug delivery products in the market.
Further, the report states that one of the major challenges in the market is a risk of overdosing, which causes various side-effects.
To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:
- Nasal spray
- Nasal drop
- Nasal powder
- Nasal gel
- Nasal vaccine
Key Vendors
- Becton, Dickinson and Company
- GlaxoSmithKline
- Johnson & Johnson
- Novartis
Other Prominent Vendors
- Actiza Pharmaceutical
- Aptar Group
- Korten Pharmaceuticals
- OptiNose
- Patheon
- Vee Remedies
-
Zymeth Wellness
For more information visit http://www.researchandmarkets.com/research/jkgp75/global_intranasal
